Skip to content

Shoulder pain after laparoscopy

Comparison of shoulder pain after injection of Intrapleural Bupivacaine with Intraperitoneal Bupivacaine after laparoscopic cholecystectomy surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013072712094N3
Enrollment
60
Registered
2013-08-30
Start date
2013-08-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cholecystectomic laparascopic. Calculus of gallbladder with other cholecystitis

Interventions

Intervention 1: intervention group 2 : intrapleural 30 ml of marcaine 0.25%. Intervention 2: control group: not injection. Intervention 3: intervention group 1 : intraperitoneal 30 ml of marcaine 0
Treatment - Drugs
intervention group 2 : intrapleural 30 ml of marcaine 0.25%
control group: not injection
intervention group 1 : intraperitoneal 30 ml of marcaine 0.25%

Sponsors

Vice Chancellor for Research, Mashhad University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Candidate for elective laparoscopic cholecystectomy; age over 18 years; ASA I-II; no history of lung disease;no history of motion sickness; no record of Addiction; no history of choledocholithiasis Exclusion criteria: require open cholecystectomy; complicate surgery; incidence of adverse events intraoperative

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Shoulder pain. Timepoint: recovery room to 24 hours later. Method of measurement: Verbal analog scale(VAS).

Secondary

MeasureTime frame
Diclofenac suppository dosage. Timepoint: 24 hours after surgery. Method of measurement: mili gram.;Paracetamol consumption. Timepoint: 24 hours after surgery. Method of measurement: mili gram.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Razavi

Mashhad University of Medical Sciences

razavim@mums.ac.ir+98 51 1852 5209

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026